Andean Silver Valuation
Is ASL undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Book vs Peers
Price-To-Book vs Industry
Price-To-Book vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ASL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate ASL's fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate ASL's fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ASL?
Key metric: As ASL barely has revenue we use its Price-To-Book Ratio for relative valuation analysis.
| What is ASL's PB Ratio? | |
|---|---|
| PB Ratio | 9.5x |
| Book | AU$16.66m |
| Market Cap | AU$157.56m |
| Key Statistics | |
|---|---|
| Enterprise Value/Revenue | 462.7x |
| Enterprise Value/EBITDA | -17.2x |
| PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does ASL's PB Ratio compare to its peers?
| Company | Forward PB | Estimated Growth | Market Cap |
|---|---|---|---|
| Peer Average | 2x | ||
MRL Mayur Resources | 2.7x | n/a | AU$121.5m |
STA Strandline Resources | 0.8x | 37.8% | AU$138.9m |
QPM Queensland Pacific Metals | 3.4x | 112.6% | AU$108.4m |
CXO Core Lithium | 0.8x | 94.0% | AU$207.9m |
ASL Andean Silver | 9.5x | 93.5% | AU$157.6m |
Price-To-Book vs Peers: ASL is expensive based on its Price-To-Book Ratio (9.5x) compared to the peer average (2x).
Price to Book Ratio vs Industry
How does ASL's PB Ratio compare vs other companies in the AU Metals and Mining Industry?
Price-To-Book vs Industry: ASL is expensive based on its Price-To-Book Ratio (9.5x) compared to the Australian Metals and Mining industry average (1.1x).
Price to Book Ratio vs Fair Ratio
What is ASL's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
| Fair Ratio | |
|---|---|
| Current PB Ratio | 9.5x |
| Fair PB Ratio | n/a |
Price-To-Book vs Fair Ratio: Insufficient data to calculate ASL's Price-To-Book Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
| Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
|---|---|---|---|---|---|---|---|
| Current | AU$1.01 | AU$2.88 +186.1% | 0.9% | AU$2.90 | AU$2.85 | n/a | 2 |
| Nov ’25 | AU$1.35 | AU$2.88 +113.8% | 0.9% | AU$2.90 | AU$2.85 | n/a | 2 |
| Oct ’25 | AU$1.22 | AU$2.70 +121.3% | 7.4% | AU$2.90 | AU$2.50 | n/a | 2 |
| Sep ’25 | AU$1.02 | AU$2.45 +141.4% | 6.1% | AU$2.60 | AU$2.30 | n/a | 2 |
Analyst Forecast: Target price is more than 20% higher than the current share price, but there are not enough analysts covering the stock to determine statistical confidence in agreement.
Discover undervalued companies
Capral
AU$156.6m
Manufactures, markets, and distributes fabricated and semi-fabricated aluminum related products in Australia.
CAA
AU$9.08
7D
-0.9%
1Y
4.5%
Nufarm
AU$1.5b
Develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific.
NUF
AU$4.03
7D
0.2%
1Y
-13.5%
Incitec Pivot
AU$6.0b
Manufactures and distributes industrial explosives, industrial chemicals, and fertilizers in Australia and the United State.
IPL
AU$3.19
7D
5.6%
1Y
11.9%